Medindia

X

Visual Mapping Reveals the Molecular Pathway for MDSC Cancer Progression

by Bidita Debnath on  October 1, 2014 at 11:15 PM Cancer News   - G J E 4
Experts from InSilico Medicine and its partners successfully established a visual mapping of the molecular pathway cancer progression originating from myeloid derived suppressor cells (MDSC).
 Visual Mapping Reveals the Molecular Pathway for MDSC Cancer Progression
Visual Mapping Reveals the Molecular Pathway for MDSC Cancer Progression
Advertisement

The damage and immune suppression the cells cause are not fully understood, however this is a major stepping stone in creating necessary transparency. Highly cited MetaCoreTM was the primary interactome analysis tool used for mapping, providing these promising results.

Advertisement
"MDSCs are elicited by tumor-derived factors from precursors present in hematopoietic organs such as the bone marrow and possibly spleen. This population of cells suppresses the activity of various types of immune cells and contributes to tumor progression by promoting tumor angiogenesis and metastasis.

But the key transcriptional regulators of MDSC are still poorly defined. Alex and colleagues used bioinformatic tools to investigate the pathway interactome maps in colon and breast cancer models. Several proliferation and invasion-related pathways were identified in infiltrating MDSC. It opens a door to new therapy targeting MDSC in these diseases. " says Qingsong Zhu, COO of InSilico Medicine, Inc.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All